Literature DB >> 29802204

Should We Accept Colistin-Induced Nephrotoxicity To Ensure Attainment of a Therapeutic Steady State in Those with Good Renal Function?

Aiden J Plant1, Cressida Auckland2.   

Abstract

Entities:  

Keywords:  clinical therapeutics; pharmacodynamics; pharmacokinetics; polymyxins; renal failure; tetracyclines

Mesh：

Substances：

Year:  2018        PMID： 29802204      PMCID： PMC5971583          DOI： 10.1128/AAC.00351-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  10 in total

Review 1.  Colistin: new lessons on an old antibiotic.

Authors:  D Yahav; L Farbman; L Leibovici; M Paul
Journal:  Clin Microbiol Infect       Date:  2012-01       Impact factor: 8.067

Review 2.  Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections.

Authors:  Jian Li; Roger L Nation; John D Turnidge; Robert W Milne; Kingsley Coulthard; Craig R Rayner; David L Paterson
Journal:  Lancet Infect Dis       Date:  2006-09       Impact factor: 25.071

3.  Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa.

Authors:  Phillip J Bergen; Jian Li; Craig R Rayner; Roger L Nation
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

4.  Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients.

Authors:  Matthew E Falagas; Petros I Rafailidis; Elda Ioannidou; Vangelis G Alexiou; Dimitrios K Matthaiou; Drosos E Karageorgopoulos; Anastasios Kapaskelis; Dimitra Nikita; Argyris Michalopoulos
Journal:  Int J Antimicrob Agents       Date:  2009-12-16       Impact factor: 5.283

5.  The Effectiveness and Safety of High-Dose Colistin: Prospective Cohort Study.

Authors:  Yael Dishon Benattar; Muna Omar; Oren Zusman; Dafna Yahav; Yael Zak-Doron; Sergey Altunin; Michal Elbaz; Vered Daitch; Michal Granot; Leonard Leibovici; Mical Paul
Journal:  Clin Infect Dis       Date:  2016-10-06       Impact factor: 9.079

6.  Dosing guidance for intravenous colistin in critically-ill patients.

Authors:  Roger L Nation; Samira M Garonzik; Visanu Thamlikitkul; Evangelos J Giamarellos-Bourboulis; Alan Forrest; David L Paterson; Jian Li; Fernanda P Silveira
Journal:  Clin Infect Dis       Date:  2016-12-23       Impact factor: 9.079

7.  Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients.

Authors:  S M Garonzik; J Li; V Thamlikitkul; D L Paterson; S Shoham; J Jacob; F P Silveira; A Forrest; R L Nation
Journal:  Antimicrob Agents Chemother       Date:  2011-05-09       Impact factor: 5.191

8.  Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system.

Authors:  Jason M Pogue; Jiha Lee; Dror Marchaim; Victoria Yee; Jing J Zhao; Teena Chopra; Paul Lephart; Keith S Kaye
Journal:  Clin Infect Dis       Date:  2011-09-07       Impact factor: 9.079

9.  Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?

Authors:  Roger L Nation; Samira M Garonzik; Jian Li; Visanu Thamlikitkul; Evangelos J Giamarellos-Bourboulis; David L Paterson; John D Turnidge; Alan Forrest; Fernanda P Silveira
Journal:  Clin Infect Dis       Date:  2015-11-25       Impact factor: 9.079

10.  A Retrospective Cohort Analysis Shows that Coadministration of Minocycline with Colistin in Critically Ill Patients Is Associated with Reduced Frequency of Acute Renal Failure.

Authors:  Thomas P Lodise; Weihong Fan; David C Griffith; Michael N Dudley; Katherine A Sulham
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.